Punjab Chemicals & Crop Protection Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 17 Jul 2026 | Fertilizers & Agrochemicals | Market Cap: ₹1.3K Cr
The company expects a revenue growth of about 15% to 20% year-on-year over the next few years. The management remains confident about growth and profit margin improvement over the next few quarters (Page 14).
From Punjab Chemicals & Crop Protection Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,148
Market Cap
₹1.3K Cr
P/E Ratio
20.1
How does Punjab Chemicals & Crop Protection Ltd rank in Fertilizers & Agrochemicals?
Compare Punjab Chemicals & Crop Protection Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Punjab Chemicals & Crop Protection Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹209 Cr, net profit ₹11 Cr.
Full financials →📊 Revenue & Sales Performance
- →The company expects a revenue growth of about 15% to 20% year-on-year over the next few years.
- →Capacity expansions and debottlenecking efforts at production sites (such as Lalru and Derabassi) aim to support higher sales volumes, targeting healthy utilizations around 80% within 4 to 6 quarters.
- →New products commercialization and MOUs are projected to generate incremental revenue of approximately INR 300-400 crores over the next 2-3 years.
- →Current capacity expansion along with new product additions could enable revenue of around INR 1,400 to INR 1,500 crores by FY 2027.
- →Export and domestic markets are expected to maintain a roughly 50-50 share, with supply chain shifts potentially altering the timing but not the overall balance.
- →Continued investment in R&D to increase the contribution of new products to 18%-20% of total revenue within the next 2 years, supporting volume and value growth.
📈 Profitability & Margins
- →The management remains confident about growth and profit margin improvement over the next few quarters (Page 14).
- →They target a 15%-20% year-on-year growth rate going forward (Page 11).
- →New products and product innovation are key drivers, with new products expected to increase their revenue share from 15-16% to 18-20% over the next 12-24 months (Page 11).
- →The introduction of new products and MOUs is expected to add incremental revenues of around INR 300-400 crores over 2-3 years (Pages 7-8).
- →EBITDA margins are expected to normalize and sustain in the 11.5%-12.5% range (Page 10).
- →Margin improvement will be supported by backward integration, operational efficiencies, and favorable product mix (Page 12).
- →Capacity utilization improvements and debottlenecking projects will support incremental revenues in FY '27 and beyond (Pages 9-10).
🏗️ Capital Expenditure Plans
- →FY 2026 capex till 9 months: ~INR 30 crores; expected additional INR 10 crores by March 2026; total ~INR 40 crores.
- →Of FY 2026 capex, ~INR 22 crores for asset renewal/compliance; ~INR 18 crores for capacity expansion/new product flexibility.
- →FY 2027 capex expected to be ~INR 70 crores, primarily starting from March 2026, focused on new production block.
- →New manufacturing block under development to support growing demand and product additions.
- →Ongoing asset renewal programs and revamp of two production blocks to improve safety, efficiency, and reliability.
- →Evaluation of new manufacturing locations underway to support medium- to long-term growth and supply chain resilience.
- →Debottlenecking at Derabassi site planned with capacity coming online by mid-February 2026, expected to boost FY 2027 revenue.
💰 Fundraising & Capital Structure
- →There is no mention of any current or future fundraising through debt or equity in the provided transcript.
- →The capex plans for FY '26 and FY '27 are funded internally, with INR40 crores planned for FY '26 and about INR70 crores anticipated for new block investments starting March FY '27.
- →The company is focusing on capacity expansion, asset renewal, and new product commercialization through internal resources and operational cash flows.
- →No discussions or announcements regarding raising capital via debt or equity were indicated during the call.
📋 Order Book & Pipeline
Key Metrics
Continue your research
What Punjab Chemicals's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Indogulf Cropsci (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…
- Rallis India (Q3 FY26)
Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…
- Sharda Cropchem (Q3 FY26)
Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…
- Krishana Phosch. (Q3 FY26)
It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Key concall takeaways from Krishana…
Frequently Asked Questions
What were Punjab Chemicals & Crop Protection Ltd Q3 FY26 results?
The company expects a revenue growth of about 15% to 20% year-on-year over the next few years. The management remains confident about growth and profit margin improvement over the next few quarters (Page 14).
What is Punjab Chemicals & Crop Protection Ltd share price analysis?
Punjab Chemicals & Crop Protection Ltd currently shows a neutral. The stock trades at a P/E of 20.1 with a market cap of ₹1,342 Cr. Investors should review the full earnings analysis for detailed insights.
Is Punjab Chemicals & Crop Protection Ltd planning capital expenditure?
FY 2026 capex till 9 months: ~INR 30 crores; expected additional INR 10 crores by March 2026; total ~INR 40 crores.
Keep Punjab Chemicals & Crop Protection Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.